RXO (RXO) Expected to Announce Quarterly Earnings on Friday

RXO (NYSE:RXO) will likely be releasing its Q4 2025 results before the market opens on Friday, February 6th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $1.4999 billion for the quarter. Interested persons may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Friday, February 6, 2026 at 8:00 AM ET.

RXO (NYSE:RXO) last posted its quarterly earnings data on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.02). RXO had a positive return on equity of 0.88% and a negative net margin of 1.25%.The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.44 billion. During the same quarter in the previous year, the firm posted $0.05 earnings per share. The company’s quarterly revenue was up 34.6% on a year-over-year basis. On average, analysts expect RXO to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

RXO Price Performance

RXO stock opened at $14.85 on Friday. The company’s fifty day moving average price is $14.01 and its 200 day moving average price is $15.20. RXO has a 1 year low of $10.43 and a 1 year high of $26.29. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.32 and a current ratio of 1.32. The stock has a market capitalization of $2.44 billion, a P/E ratio of -34.52, a P/E/G ratio of 7.13 and a beta of 1.74.

Insider Activity

In other RXO news, CEO Andrew M. Wilkerson bought 7,775 shares of the stock in a transaction on Monday, November 10th. The shares were purchased at an average price of $12.88 per share, with a total value of $100,142.00. Following the acquisition, the chief executive officer directly owned 7,775 shares of the company’s stock, valued at $100,142. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Troy A. Cooper purchased 8,317 shares of RXO stock in a transaction on Thursday, November 20th. The stock was purchased at an average price of $10.61 per share, for a total transaction of $88,243.37. Following the completion of the transaction, the director owned 275,416 shares of the company’s stock, valued at approximately $2,922,163.76. This represents a 3.11% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought a total of 40,250 shares of company stock worth $488,875 in the last three months. 2.80% of the stock is owned by insiders.

Hedge Funds Weigh In On RXO

Several hedge funds and other institutional investors have recently bought and sold shares of the company. CIBC Bancorp USA Inc. bought a new position in RXO during the third quarter worth $267,000. PharVision Advisers LLC purchased a new stake in shares of RXO in the third quarter worth $203,000. Voloridge Investment Management LLC bought a new position in shares of RXO during the 3rd quarter valued at about $7,372,000. Quarry LP bought a new position in shares of RXO in the third quarter worth approximately $33,000. Finally, Mariner LLC bought a new position in RXO in the 3rd quarter worth $494,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. Citigroup cut their target price on shares of RXO from $16.00 to $15.00 and set a “neutral” rating on the stock in a report on Thursday, January 8th. Susquehanna upped their price objective on shares of RXO from $10.00 to $11.00 and gave the company a “negative” rating in a research note on Thursday, January 8th. TD Cowen restated a “hold” rating on shares of RXO in a report on Friday, January 9th. UBS Group decreased their target price on shares of RXO from $17.00 to $15.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Finally, JPMorgan Chase & Co. boosted their target price on shares of RXO from $15.00 to $16.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 8th. Four research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $16.14.

About RXO

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.